Initial public offerings scheduled to debut next week

NEW YORK, N.Y. – The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.

Week of May 2:

Caner Prevention Pharmaceuticals – Tucson, Ariz., 2 million shares, priced $12-$14, managed by Aegis Capital Corp. Proposed NYSE MKT symbol CPP. Business: Developing treatments for colorectal cancer risk factors.

Intellia Therapeutics – Cambridge, Mass., 5 million shares, priced $16-18, managed by Credit Suisse/Jefferies/Leerink Partners. Proposed Nasdaq symbol NTLA. Business: Biotech therapies.

Oncobiologics – Cranbury, N.J., 5 million shares, priced $11-$13, managed by Jefferies/Barclays. Proposed Nasdaq symbol ONS. Business: Pharmaceutical research.

Spring Bank Pharmaceuticals – Hopkinton, Mass., 1.2 million shares, priced $12-14, managed by Dawson James. Proposed Nasdaq symbol SBPH. Business: Development of molecule therapy for hepatitis B and viral diseases.